UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000047156
Receipt number R000053793
Scientific Title Randomized comparative study of third-generation Narrow band imaging (NBI) and White light imaging (WLI) in the diagnosis of the presence of early gastric cancer.
Date of disclosure of the study information 2022/04/01
Last modified on 2023/09/12 10:47:06

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Randomized comparative study of third-generation Narrow band imaging (NBI) and White light imaging (WLI) in the diagnosis of the presence of early gastric cancer.

Acronym

Detection of early gastric cancer by 3rd generation NBI

Scientific Title

Randomized comparative study of third-generation Narrow band imaging (NBI) and White light imaging (WLI) in the diagnosis of the presence of early gastric cancer.

Scientific Title:Acronym

Detection of early gastric cancer by 3rd generation NBI

Region

Japan


Condition

Condition

Early stage gastric cancer

Classification by specialty

Gastroenterology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

Proof that Third Generation NBI Non-Expanded Observation is More Useful than WLI Observation in Diagnosing the Presence of Early Gastric Cancer.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

detection rate of early gastric cancer

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Single blind -participants are blinded

Control

No treatment

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Diagnosis

Type of intervention

Other

Interventions/Control_1

Prior WLI observation and posterior NBI non-expanded observation

Interventions/Control_2

Prior NBI non-expansion observation and posterior WLI observation

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients with curative resection who underwent endoscopic treatment for early stage gastric cancer

Key exclusion criteria

Post gastrectomy
Endoscopic treatment non curative resection

Target sample size

566


Research contact person

Name of lead principal investigator

1st name Yukihisa
Middle name
Last name Fujinaga

Organization

Nara Medical University

Division name

Department of Gastroenterology

Zip code

634-8522

Address

840 Shijo-cho, Kashihara, Nara, Japan

TEL

0744-22-3051

Email

3naika@naramed-u.ac.jp


Public contact

Name of contact person

1st name Yukihisa
Middle name
Last name Fujinaga

Organization

Nara Medical University

Division name

Department of Gastroenterology

Zip code

634-8522

Address

840 Shijo-cho, Kashihara, Nara, Japan

TEL

0744-22-3051

Homepage URL


Email

3naika@naramed-u.ac.jp


Sponsor or person

Institute

Nara Medical University

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Nara Medical University Medical Ethics Review Committee

Address

840 Shijo-cho, Kashihara, Nara, Japan

Tel

0744-22-3051

Email

ino_rinri@naramed-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2022 Year 04 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2021 Year 11 Month 08 Day

Date of IRB

2022 Year 03 Month 10 Day

Anticipated trial start date

2022 Year 04 Month 01 Day

Last follow-up date

2024 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2022 Year 03 Month 12 Day

Last modified on

2023 Year 09 Month 12 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000053793